Idexx Laboratories Q3 FY26: where the revenue came from and where it went
The whole income statement of Idexx Laboratories for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2026
- Reported
- Nov 2, 2026
Revenue$1.21B
+10% year over year
Gross profit$0.76B
63% margin
Operating profit$0.40B
33% margin
Net profit$0.32B
26% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.21 | 100% | +10% |
| IDEXX VetLab consumables | 0.44 | 37% | +14% |
| Reference laboratory | 0.40 | 33% | +10% |
| Rapid assay products | 0.09 | 7% | +1% |
| Recurring | 0.08 | 6% | +9% |
| Other | 0.06 | 5% | |
| Water segment | 0.06 | 5% | +8% |
| capital - instruments | 0.05 | 4% | +0% |
| services & accessories | 0.04 | 3% | +5% |
| Cost of revenue | −0.45 | 37% | |
| Gross profit | 0.76 | 63% margin | +1pp |
| R&D | −0.07 | 6% | +0pp |
| Sales & marketing | −0.17 | 14% | +0pp |
| G&A | −0.12 | 10% | +1pp |
| Operating profit | 0.40 | 33% margin | +1pp |
| Tax | −0.09 | ||
| Net profit | 0.32 | 26% margin | +1pp |
4 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest